Gut microbiota-based prediction of clinical response to sublingual immunotherapy in Artemisia pollen-induced allergic rhinitis: A prospective cohort study
Acta Microbiologica et Immunologica Hungarica · 2026
DOI: 10.1556/030.2026.02831 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2026. Verfasst von Fei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Otorhinolaryngology, International Mongolian Hospital of Inner Mongolia, 010062, Hohhot City, Inner Mongolia Autonomous Region, China. Hauptthemen laut MEDLINE: Sublingual Immunotherapy, Pollen, Gastrointestinal Microbiome, Artemisia. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Emergency and Critical Care Center, International Mongolian Hospital of Inner Mongolia.
Abstract (Originalsprache)
The gut microbiota plays a crucial role in modulating mucosal immunity and allergic responses, yet its predictive value for sublingual immunotherapy (SLIT) outcomes remains underexplored in Artemisia pollen-induced allergic rhinitis (AR). In this single-center prospective cohort study, 204 adults with Artemisia pollen-induced AR underwent baseline stool collection before initiating standardized SLIT. Gut microbiota was analyzed using 16S rRNA sequencing of the V3–V4 region, with prespecified features including Shannon diversity index, composite abundance of butyrate-producing bacteria (Faecalibacterium, Roseburia, Eubacterium rectale group), and Prevotella-to-Bacteroides (P/B) ratio. Clinical response was defined as ≥30% reduction in combined symptom-medication score (CSMS) during the peak pollen season. We developed three prediction models: Model A (clinical variables only), Model B (clinical variables plus microbiota features), and Model C (parsimonious model via L1 regularization). The response rate was 54.41% (111/204). In multivariable analysis, all three microbiota features independently predicted treatment response: butyrate-producing bacteria (OR = 1.59, q = 0.006), P/B ratio (OR = 1.43, q = 0.020), and Shannon diversity (OR = 1.33, q = 0.046). Model B demonstrated superior discrimination compared to Model A (AUC 0.79 vs 0.71, ΔAUC = 0.08, P = 0.021), with improved calibration (intercept α = −0.03, slope β = 0.98) and significant net reclassification improvement (NRI = 0.36, P = 0.002). Decision curve analysis confirmed greater net benefit across clinically relevant threshold probabilities. The parsimonious Model C maintained good performance (optimism-corrected AUC = 0.78) with 77.48% sensitivity and 72.04% specificity. Baseline gut microbiota characteristics, particularly butyrate-producing bacterial abundance, microbial diversity, and Prevotella/Bacteroides community structure, significantly predict SLIT response in Artemisia pollen-induced AR and provide substantial incremental value over conventional clinical parameters. These findings support the integration of gut microbiota assessment into pretreatment stratification algorithms for allergen immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Otorhinolaryngology, International Mongolian Hospital of Inner Mongolia, 010062, Hohhot City, Inner Mongolia Autonomous Region, China.
- 2Innovation Center of Ethnic Medicine, Inner Mongolia Medical University, 010110, Hohhot City, Inner Mongolia Autonomous Region, China.
- 3Emergency and Critical Care Center, International Mongolian Hospital of Inner Mongolia, 010062, Hohhot City, Inner Mongolia Autonomous Region, China.
Förderung
- Emergency and Critical Care Center, International Mongolian Hospital of Inner Mongolia
Zitieren
APA
Wang, F., Yang, J., Bao, L., Ya'nan, & Jin, B. (2026). Gut microbiota-based prediction of clinical response to sublingual immunotherapy in Artemisia pollen-induced allergic rhinitis: A prospective cohort study. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2026.02831
Vancouver
Wang F, Yang J, Bao L, Ya'nan, Jin B. Gut microbiota-based prediction of clinical response to sublingual immunotherapy in Artemisia pollen-induced allergic rhinitis: A prospective cohort study. Acta Microbiologica et Immunologica Hungarica. 2026. doi:10.1556/030.2026.02831
BibTeX
@article{Wang2026,
author = {Wang, Fei and Yang, Jinjin and Bao, Liming and Ya'nan, Ya'nan and Jin, Bat},
title = {Gut microbiota-based prediction of clinical response to sublingual immunotherapy in Artemisia pollen-induced allergic rhinitis: A prospective cohort study},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2026},
doi = {10.1556/030.2026.02831}
}
EUVIMED